Diabetes biotech Viking Therapeutics sets terms for $55 million IPO


Viking Therapeutics, a biotech developing treatments for diabetes and other metabolic and endocrine disorders, announced terms for its IPO on Tuesday. The San Diego, CA-based company plans to raise $55 million by offering 5 million shares at a price range of $10 to $12. At the midpoint of the proposed range, Viking Therapeutics would command a market value of $167 million.

The company has five drug candidates based on small molecules licensed from Ligand Pharmaceuticals ( LGND ), which intends to purchase $5 million (9%) worth of shares on the offering. Viking's lead candidate is an oral treatment entering Phase 2b trials for type 2 diabetes. Its second clinical program is entering Phase 2 trials for cancer cachexia.

Viking Therapeutics, which was founded in 2012, plans to list on the NASDAQ under the symbol VKTX. Oppenheimer and Roth Capital are the joint bookrunners on the deal. It is expected to price during the week of September 15, 2014.

The article Diabetes biotech Viking Therapeutics sets terms for $55 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: News Headlines , IPOs

Referenced Stocks: LGND , VKTX

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos



Most Active by Volume

  • $16.885 ▲ 1.29%
  • $10.23 ▲ 0.99%
  • $5.445 ▲ 5.52%
  • $35.0465 ▲ 2.00%
  • $32.697 ▼ 1.72%
  • $8.93 ▲ 0.11%
  • $82.27 ▲ 2.27%
  • $13.22 ▲ 1.85%
As of 6/3/2015, 12:22 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com